Regulators expect brokerage firms to maintain controls designed to prevent the firm from submitting orders to market centers that create a risk of disruptive trading (e.g., the risk of sudden, transient price moves).
To comply with these expectations, Interactive Brokers implements various price filters on customer orders. Those price filters may, in certain circumstances, price cap customer orders in order to avoid market disruption, and those Price Caps will generally be in a % range from a reference price range calculated by IB. (The range of the Price Cap varies depending on the type of instrument and the current price.)
Although the price caps are intended to balance the objectives of trade certainty and minimized price risk, a trade may be delayed or may not take place as a result of price capping. More information is available in Interactive Broker’s Order Routing and Payment for Order Flow Disclosure.
If a customer’s order(s) are price capped by IB’s systems, that customer will either receive (i) real-time notification of those price cap(s) in Trader Workstation or via the API or FIX tag 58 (for FIX users); and/or (ii) a daily FYI message containing a digest of the first 10 order(s) that were price capped the prior day, the initial price cap(s) for those order(s) (if applicable), and the Price Cap Range(s) for further Price Cap(s) of those order(s).
Customers may opt out from receiving future FYI Messages by clicking the relevant opt-out link within an FYI Message. By opting out from receiving these future FYI Messages, a customer:
Trading fractional shares allows you to invest in companies which you may not be able to afford the full share price. It also makes it easier for you to diversify your portfolio by allowing you to purchase fractional amounts in multiple companies when you otherwise may have only been able to purchase whole shares in one or two companies.
If you enable your account to trade in fractions, we will buy or sell a fraction of a share based on the amount of cash you specify. For example, if you want to spend $500 but one share of the stock you want to buy is currently $1000 you would end up with 0.5 shares.
Who is eligible for fractional share permissions?
All individual, standalone accounts (except those who reside in Israel, Canadian RRSP/TFSA accounts and Interactive Brokers Securities Japan Inc. ("IBSJ") entity accounts) are eligible for fractional share permissions.
Financial Advisors, Money Managers, and Introducing Brokers may enable their clients on an all-or-none basis.
How do I enable fractional shares?
If you are eligible then you can enable fractional share trading in Client Portal. Click the User menu (head and shoulders icon in the top right corner) followed by Settings. Under Account Settings find the section Trading and click on Trading Permissions. Scroll to "Stocks", click +Add and check the box next to "Global (Trade in Fractions)" and click on SAVE. Then click CONTINUE and follow the prompts on screen. You will then be able to trade in fractions in eligible stocks for which you have permission to trade. To trade fractions of eligible U.S. stocks, you will need to sign up to trade U.S. stocks, and to trade fractions of eligible European stocks, you will need to sign up to trade European stocks.
Please note, TWS Build Version 979 or later is required to trade fractional shares. This feature currently supports most order types.
What products can I trade in fractions?
We offer fractional share trading on eligible U.S., Canadian and European stocks and ETFs*.
A list of eligible stocks that can be traded in fractional shares is available via the following link. Please note, this list is subject to change without notice:
http://www.ibkr.com/download/fracshare_stk.csv
*Under EU regulations, EU retail clients generally cannot trade U.S. ETFs, in whole or fractional increments.
Can I short fractional shares?
IBKR does support short sales in fractional shares of eligible stocks as long as you have margin and approved trading permissions to trade fractional shares of stocks listed in the U.S. or in Europe.
What are the fees associated with fractional shares?
There is no additional fee to use fractional share trading. Standard commission rates (both IBKR Lite and IBKR Pro, where applicable) apply.
What order types can I choose for fractional trading?
IBKR will only accept certain types of orders for fractional shares (e.g., market orders, limit orders, stop orders, stop limit orders, etc.). If you choose to place an unmarketable limit order with a fractional share component, the fractional component may not execute until the order becomes marketable (and therefore may not execute at all), even if the order might have executed earlier if submitted for a whole share quantity.
How does IBKR handle fractional shares orders in European stocks?
Depending on the size and nature of the order, IBKR will direct orders in European stocks that include a fractional share component to a pool of execution venues which might be different than those utilized for other order types. You should review the applicable order execution policy for more details.
Can I transfer fractional shares to IBKR?
IBKR does not accept fractional shares through a position transfer.
Are fractional shares eligible for the Dividend Reinvestment Program (DRIP)?
Yes, it is possible to receive fractional shares for a reinvested dividend through the Dividend Reinvestment Program (DRIP) if the account has fractional share permissions.
Please note the above does not apply in the event of mutual fund dividends, which can be re-invested and may result in holding fractional shares of the fund.
Will I receive a fractional share position from a corporate action?
If your account has been approved for trading fractions and a US or European corporate action issues fractional shares, the fractional shares will remain in your account. However, if your account does not have permissions to trade in fractions or the corporate action is issuing non-eligible shares, the fractional shares will be liquidated.
Will I have voting rights for fractional shares in my account?
You will not have voting rights for any of the fractional shares held in your account, you will not be able to make voluntary elections on any corporate action (including, without limitation, any tender offers or rights offerings) with respect to such fractional shares, and we cannot provide you any other shareholder documentation for any holdings of less than one share.
Do I receive dividends on my fractional shares?
Your fractional shares positions are eligible to receive dividends in the same manner as your full positions on the same stocks.
Is fractional trading available for the API?
Fractional trading is supported via FIX/CTCI but not via API at this time.
背景
2018年,一项欧盟新规生效,该新规旨在对“零售”客户进行保护,确保其在买入某种产品时能够获得充分的披露信息。该法规被称为零售及保险投资产品组合法规(MiFID II指令2014/65/EU)或PRIIP,其覆盖了所有应付给客户的金额会受参考值或一种或多种并非由该等零售投资者直接买入之资产的业绩表现影响而波动的投资。常见列子包括期权、期货、差价合约、ETF、ETN和其它结构性产品。
值得注意的是,经纪商不得允许零售客户购买PRIIP覆盖的产品,除非该产品的发行机构已经备好了要求的披露文件让经纪商提供给客户。这种披露文件被称为关键信息文件(“KID”),包括产品描述、成本、风险回报情况及可能的业绩情境等信息。美国客户不受PRIIP影响,因此,某些美国挂牌ETF的发行机构通常不会创建关键信息文件。这就意味着,欧洲经济区(“EEA”)的零售客户可能无法购买此类产品。
客户分类
IBKR默认将所有个人客户分类为“零售”客户,因为这样可以给与客户MiFID提供的最广泛的保护。被分类为“专业”客户的客户无法享受“零售”客户级别的保护,但同时也不需要受KID文件要求的限制。根据MiFID II的定义,“专业”客户包括受监管的实体、大型客户和要求被重新分类为“选择性专业客户”并且在知识、经验和财务实力方面满足MiFID II要求的个人。
IB提供了线上程序可供“零售”客户申请将其分类更改为“专业”。重新分类的资格要求以及申请重新分类的步骤,请参见KB3298,如果要直接申请更改分类,可通过客户端/账户管理中的相关问卷进行。
BACKGROUND
In 2018, an EU regulation, intended to protect “Retail” clients by ensuring that they are provided with adequate disclosure when purchasing certain products took effect. This disclosure document is referred to as a Key Information Document, or KID, and it contains information such as product description, cost, risk-reward profile and possible performance scenarios.
This regulation is known as the Packaged Retail and Insurance-based Investment Product Regulation (MiFID II, Directive 2014/65/EU), or PRIIPs, and it covers any investment where the amount payable to the client fluctuates because of exposure to reference values or to the performance of one or more assets not directly purchased by such retail investor. Common examples of such products include options, futures, CFDs, ETFs, ETNs and other structured products.
The UK Financial Conduct Authority (FCA) has equivalent requirements for UK residents.
It’s important to note that a broker cannot allow a Retail client to purchase a product covered by PRIIPs unless the issuer of that product has prepared the required disclosure document for the broker to provide to the client. U.S. clients are not impacted by PRIIPs, so the issuers of U.S. listed ETFs do not as a rule create KIDs. This means that EEA and UK Retail clients may not purchase the product. Clients nevertheless have several options:
CLIENT CATEGORISATION
We categorize all individual clients as “Retail” by default as this affords clients the broadest level of protection afforded by MiFID. Client who are categorised as “Professional” do not receive the same level of protection as “Retail” but are not subject to the KIDs requirement. As defined under MiFID II rules, “Professional” clients include regulated entities, large clients and individuals who have asked to be re-categorised as “elective professional clients” and meet the MiFID II requirements based on their knowledge, experience and financial capability.
We provide an online step-by-step process that allows “Retail” to request that their categorisation be changed to “Professional". The qualifications for re-categorisation along with the steps for requesting that one’s categorisation be considered are outlined in KB3298 or, to directly apply for a change in categorisation, the questionnaire is available in the Client Portal/Account Management.
简介
2019年1月30日,iPath S&P 500 VIX短期期货(VXX)和中期期货(VXZ)交易所交易票据(ETN)即将到期。考虑到VXX和VXZ即将到期,其发行机构巴克莱银行发行了iPath“B系列”的S&P 500 VIX短期期货(VXXB)和中期期货(VXZB)交易所交易票据,于2018年1月开始交易,并将于2048年到期。
持有与即将到期的ETN及/或其衍生产品相关之头寸的客户应熟悉事件的时间安排、可做的选择以及相关风险和保证金影响。请注意,如不采取相应行动,或采取行动时不考虑保证金影响,可能会将您的账户置于不符合保证金要求的境地,从而导致强制清算。
下方常见问题提供了与该事件相关的背景信息。
常见问题解答
问:VXX和VXZ交易所交易票据何时到期?答:VXX和VXZ将在2019年1月30日开盘时到期并摘牌。问:VXX和VXZ的最后交易日是哪天?
答:2019年1月29日将会是该等即将到期之ETN的最后交易日和最后估值日。
问:到期后VXX和VXZ会如何处理?
答:发行机构为VXX和VXZ的持有者提供了选择,即赎回票据兑换现金或以1:1的比例兑换对应的“B系列”票据。或者,该等票据持有者还可选择在2019年1月30日前平仓并将头寸替换成二级市场上对应的“B系列”票据。
问:如果赎回兑现该等即将到期的票据,可以获得多少现金?
答:如选择兑现票据,您每张票据可获得的现金将等于2019年1月29日(即最后估值日)所适用的收盘指示性价值。
问:赎回交易何时会记入我的账户?
答:赎回交易,无论是兑现还是兑换“B系列”票据,都会在2019年1月29日收盘后处理,并会于2019年1月30日开盘前记入您的账户。
问:如何将我的赎回决定告知IBKR?
答:我们会通过消息中心和电子邮箱向多头持有即将到期之头寸的客户发送通知,届时会开放选择窗口。通知会详细说明如何通过客户端/账户管理内的自愿公司行动工具提交选择。
问:是否可以选择提早赎回?
答:客户可以在到期前提早赎回票据兑换“B系列”票据或现金(即提前赎回),但需付$500.00美元费用。到期赎回没有费用。
问:选择决定是否可以撤销?
答:提前赎回选择不可撤销。到期赎回选择在选择窗口关闭前均可撤销。
问:IBKR是否支持现金和“B系列”票据结合的方式赎回?答:不支持。客户只可在全现金和全“B系列”票据之间选择一个。问:如果在选择窗口关闭前没有提供选择决定会怎么样?
答:如果您决定不采取行动或未能在截止时间前采取行动,到期头寸将兑换为现金。
问:如果在最后交易日前持有即将到期票据的空头头寸会怎么样?
答:如果在最后交易日前持有即将到期票据的空头头寸,出借方有权平仓您的空头头寸,强制您交付现金或对应的“B系列”票据。如果您没有足够数量的“B系列”票据多头头寸可供交付,则您会被分配一个空头头寸,如果无法借到该ETN,您将面临强制平仓。
问:如果在最后交易日后持有即将到期票据的空头头寸会怎么样?
答:如果在最后交易日后持有即将到期票据的空头头寸,则您必须交付现金。
问:与该事件相关的保证金影响有哪些?
答:在投资组合保证金账户中持有即将到期ETN的客户需要特别注意票据到期和赎回选择对其保证金要求的影响。尽管VXX、VXZ及其相关衍生品列入了美国货币监理署(OCC)的客户投资组合保证金文件,IB对这些产品提供投资组合保证金交易,但其对应的“B系列”票据并没有列入OCC的投资组合保证金文件,因此IBKR不会对该等产品提供投资组合保证金交易。这些“B系列”ETN和衍生品将根据Reg.T规定计算保证金要求。
因此,在当前投资组合保证金框架下支持的VXX和其它短期波动率产品(如VIXY、VIIX、UVXY、TVIX和SVXY)之间的保证金对销将不会适用于VXXB。同样,当前支持的VXZ和其它中期波动率产品(如VIXM和ZIV)之间的保证金对销也不会适用于VXZB。此外,由于Reg. T只对一部分期权策略提供保证金减免,Reg.T保证金框架下持有包含VXXB或VXZB的复合期权头寸的客户其保证金要求可能会高于投资组合保证金框架下对应VXX或VXZ头寸的保证金要求。
客户可通过在风险漫游中创建“What-if“投资组合来模拟VXX和VXZ到期的影响以及相关赎回选择。
注:如果赎回即将到期的ETN将其兑换成对应的“B系列”票据会导致账户保证金不足,IBKR有权禁止该等赎回,并强制进行现金赎回。
斯图加特交易所(Boerse Stuttgart)和明讯银行(Clearstream Banking)宣布其将不再对主营业务与大麻及其它毒品直接或间接相关的证券提供服务。因此,该等证券将不会再于斯图加特(SWB)或法兰克福(FWB)证券交易所交易。自2018年9月19日收盘开始,IBKR将采取以下行动:
下方表格列出了斯图加特交易所和明讯银行截至2018年8月7日公布的受影响证券。该表格还标记了受影响证券是否能够转至美国挂牌市场。注意,清算所已声明该列表可能尚不完整,建议客户检查其各自网站了解最新信息。
ISIN | 名称 | 交易所 | 是否可转至美国? | 美国代码 |
CA00258G1037 |
ABATTIS BIOCEUTICALS CORP |
FWB2 | 是 |
ATTBF |
CA05156X1087 |
AURORA CANNABIS INC |
FWB2, SWB2 | 是 |
ACBFF |
CA37956B1013 |
GLOBAL CANNABIS APPLICATIONS |
FWB2 | 是 |
FUAPF |
US3988451072 |
GROOVE BOTANICALS INC |
FWB | 是 |
GRVE |
US45408X3089 |
INDIA GLOBALIZATION CAPITAL |
FWB2, SWB2 | 是 |
ICG |
CA4576371062 |
INMED PHARMACEUTICALS INC |
FWB2 | 是 |
IMLFF |
CA53224Y1043 |
LIFESTYLE DELIVERY SYSTEMS I |
FWB2, SWB2 | 是 |
LDSYF |
CA56575M1086 |
MARAPHARM VENTURES INC |
FWB2, SWB2 | 是 |
MRPHF |
CA5768081096 |
MATICA ENTERPRISES INC |
FWB2, SWB2 | 是 |
MQPXF |
CA62987D1087 |
NAMASTE TECHNOLOGIES INC |
FWB2, SWB2 | 是 |
NXTTF |
CA63902L1004 |
NATURALLY SPLENDID ENT LTD |
FWB2, SWB2 | 是 |
NSPDF |
CA88166Y1007 |
TETRA BIO-PHARMA INC |
FWB2 | 是 |
TBPMF |
CA92347A1066 |
VERITAS PHARMA INC |
FWB2 | 是 |
VRTHF |
CA1377991023 |
CANNTAB THERAPEUTICS LTD |
FWB2 | 否 | |
CA74737N1042 |
QUADRON CANNATECH CORP |
FWB2 | 否 | |
CA84730M1023 |
SPEAKEASY CANNABIS CLUB LTD |
FWB2, SWB2 | 否 | |
CA86860J1066 |
SUPREME CANNABIS CO INC/THE |
FWB2 | 否 | |
CA92858L2021 |
VODIS PHARMACEUTICALS INC |
FWB2 | 否 |
重要注意事项:
Boerse Stuttgart and Clearstream Banking have announced that they will no longer provide services for issues whose main business is connected directly or indirectly to cannabis and other narcotics products. Consequently, those securities will no longer trade on the Stuttgart (SWB) or Frankfurt (FWB) stock exchanges. Effective as of the 19 September 2018 close, IBKR will take the following actions:
Outlined in the table below are impacted issues as announced by the Boerse Stuttgart and Clearstream Banking as of 7 August 2018. This table includes a notation as to whether the impacted issue is eligible for transfer to a U.S. listing. Note that the clearinghouses have indicated that this list may not yet be complete and clients are advised to review their respective websites for the most current information.
ISIN | NAME | EXCHANGE | U.S. TRANSFER ELIGIBLE? | U.S. SYMBOL |
CA00258G1037 |
ABATTIS BIOCEUTICALS CORP |
FWB2 | YES |
ATTBF |
CA05156X1087 |
AURORA CANNABIS INC |
FWB2, SWB2 | YES |
ACBFF |
CA37956B1013 |
GLOBAL CANNABIS APPLICATIONS |
FWB2 | YES |
FUAPF |
US3988451072 |
GROOVE BOTANICALS INC |
FWB | YES |
GRVE |
US45408X3089 |
INDIA GLOBALIZATION CAPITAL |
FWB2, SWB2 | YES |
ICG |
CA4576371062 |
INMED PHARMACEUTICALS INC |
FWB2 | YES |
IMLFF |
CA53224Y1043 |
LIFESTYLE DELIVERY SYSTEMS I |
FWB2, SWB2 | YES |
LDSYF |
CA56575M1086 |
MARAPHARM VENTURES INC |
FWB2, SWB2 | YES |
MRPHF |
CA5768081096 |
MATICA ENTERPRISES INC |
FWB2, SWB2 | YES |
MQPXF |
CA62987D1087 |
NAMASTE TECHNOLOGIES INC |
FWB2, SWB2 | YES |
NXTTF |
CA63902L1004 |
NATURALLY SPLENDID ENT LTD |
FWB2, SWB2 | YES |
NSPDF |
CA88166Y1007 |
TETRA BIO-PHARMA INC |
FWB2 | YES |
TBPMF |
CA92347A1066 |
VERITAS PHARMA INC |
FWB2 | YES |
VRTHF |
CA1377991023 |
CANNTAB THERAPEUTICS LTD |
FWB2 | NO | |
CA74737N1042 |
QUADRON CANNATECH CORP |
FWB2 | NO | |
CA84730M1023 |
SPEAKEASY CANNABIS CLUB LTD |
FWB2, SWB2 | NO | |
CA86860J1066 |
SUPREME CANNABIS CO INC/THE |
FWB2 | NO | |
CA92858L2021 |
VODIS PHARMACEUTICALS INC |
FWB2 | NO |
IMPORTANT NOTES: